CTAD 2026

Faradji et al

 

Real-World Patient-Reported Outcomes with Subcutaneous Lecanemab Treatment in Early Alzheimer’s Disease in the United States: A Case Series

Copies of these presentations obtained through the QR code are for personal use only and may not be used without permission from CTAD and the authors of this presentation.